Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;36(8):e24590.
doi: 10.1002/jcla.24590. Epub 2022 Jul 8.

Serum uric acid to creatinine ratio is associated with higher prevalence of NAFLD detected by FibroScan in the United States

Rusha Wang  1 , Feiben Xue  1 , Liping Wang  1 , Guangxia Shi  1 , Guoqing Qian  1 , Naibin Yang  1 , Xueqin Chen  2
Affiliations

Serum uric acid to creatinine ratio is associated with higher prevalence of NAFLD detected by FibroScan in the United States

Rusha Wang et al. J Clin Lab Anal. 2022 Aug.

Abstract

Background: The association between the serum uric acid (sUA) to creatinine ratio (sUA/Cr) and non-alcoholic fatty liver disease (NAFLD) has not been sufficiently clarified. In this study, we investigated the relationship between sUA/Cr and NAFLD among participants in the United States.

Methods: We performed a cross-sectional study based on data from the National Health and Nutrition examination Survey (NHANES) 2017-2018. A measured controlled attenuation parameter (CAP) value of ≥274 dB/m detected by Fibroscan was used to identify hepatic steatosis. SUA/Cr was calculated as sUA divided by serum creatinine. Multivariate logistic regression analysis was used to estimate the association between sUA/Cr and NAFLD. The adjusted odds ratio (OR) of sUA/Cr for NAFLD was estimated, and subgroup analysis stratified by sex was also conducted. The nonlinear relationship between sUA/Cr and NAFLD was further described using smooth curve fittings and threshold-effect analysis.

Results: We found that sUA/Cr was positively correlated with NAFLD status after fully adjustment for confounding factors. In subgroup analysis stratified by sex, the positive interaction between sUA/Cr and NAFLD status only existed in women but not in men. Moreover, the nonlinear association between sUA/Cr and NAFLD status was an inverted U-shaped curve with an inflection point at 9.7 among men.

Conclusions: Our study identified that sUA/Cr was positively associated with the risk of NAFLD among individuals in the United States. Moreover, the correlation between sUA/Cr and NAFLD differed according to sex.

Keywords: NAFLD; NHANES; inflammation; serum uric acid to creatinine ratio; steatosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

FIGURE 1
FIGURE 1
Flowchart of subjects included in this study
FIGURE 2
FIGURE 2
Associations between serum uric acid to creatinine ratio and CAP values or prevalence of NAFLD. (A) and (C): Each black point represents a sample. (B) and (D): Solid redline represents the smooth curve fit between variables. Blue bands represent the 95% of confidence interval from the fit. Adjusted for: sex, age, race, BMI, diabetes status, SBP, DBP, ALT, AST, GGT, glycohemoglobin, HDL‐cholesterol, total cholesterol, triglyceride, and serum albumin
FIGURE 3
FIGURE 3
Association between sUA/Cr and prevalence of NAFLD stratified by sex. Adjusted for: age, race, BMI, diabetes status, SBP, DBP, ALT, AST, GGT, glycohemoglobin, HDL‐cholesterol, total cholesterol, triglyceride, and serum albumin
See this image and copyright information in PMC

References

    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease‐Meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73‐84. - PubMed
    1. Friedman SL, Neuschwander‐Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908‐922. - PMC - PubMed
    1. European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O . EASL‐EASD‐EASO Clinical Practice Guidelines for the management of non‐alcoholic fatty liver disease. J Hepatol. 2016;64:1388‐1402. - PubMed
    1. Rinella ME, Sanyal AJ. Management of NAFLD: a stage‐based approach. Nat Rev Gastroenterol Hepatol. 2016;13:196‐205. - PubMed
    1. Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47‐S64. - PubMed